How to start the conversation with your doctor.
Text Size  A  A  A
Print this Page
Email a Friend
Newsroom
RAPAFLO Promise Seal

Introducing the RAPAFLO® Promise

The RAPAFLO Promise

Watson is committed to helping patients live better. If RAPAFLO does not meet your needs, we will reimburse up to a $50 copay for the first time you use another prescription treatment (terazosin, doxazosin, tamsulosin, or alfuzosin).

Who is eligible?

  • Patients who are new to therapy with RAPAFLO and have paid for 1 month of RAPAFLO therapy and used it as prescribed*

How does the RAPAFLO Promise work?

  • Within 60 days of filling the prescription for the competitive product, just request THE RAPAFLO PROMISE materials from your physician's office. You will need to send in the following documentation:
    • The signed RAPAFLO Promise Registration Card (from your physician's office)
    • Pharmacy receipts for 1 month of RAPAFLO therapy and a 1-month supply of competitor's product. Receipt must show the total out-of-pocket cost for the new prescription and the name of the product being purchased

RAPAFLO is available only by prescription. For patients with no prescription insurance coverage, Watson has created the RAPAFLO patient assistance program for qualifying patients. For more information, please visit http://www.rapaflo.com/how-help-afford.asp

*Patients may have taken another prescription treatment prior to beginning RAPAFLO therapy.

Terms and Conditions

  • Patients must be new to therapy with RAPAFLO but could have previously taken a competing product prior to beginning RAPAFLO therapy
  • Patients receiving copay assistance for RAPAFLO are eligible
  • Patients must provide proof of 1 paid month of therapy with RAPAFLO, proof of purchase of competing product, and the card attached to the patient information leaflet
  • Offer expires 60 days after the date the prescription for the competitive product (terazosin, doxazosin, tamsulosin, or alfuzosin) is filled at the pharmacy
  • Patients cannot be receiving copay assistance or free product from manufacturer of competing product
  • Total patient reimbursement is limited to $50 or actual out-of-pocket cost, whichever is lower
  • Watson reserves the right to rescind, revoke, or amend this offer without notice at any time
  • Watson will not sell or rent patient’s personal information to others
  • This offer is not valid for individuals who are covered on Medicaid, Medicare, TriCare, or any other state or federal healthcare program
  • Not valid for residents of Massachusetts, Rhode Island, or anywhere else prohibited by law
  • Offer good only in the United States and Puerto Rico

RAPAFLO is indicated for the treatment of the signs and symptoms of benign prostatic hyperplasia (BPH).

RAPAFLO is not indicated for the treatment of hypertension.

Important Safety Information

RAPAFLO is approved to treat male urinary symptoms due to BPH, also called an enlarged prostate. RAPAFLO should not be used to treat high blood pressure. Only your doctor can tell if you have BPH, not a more serious condition like prostate cancer. RAPAFLO should not be used in patients with severe liver or kidney disease as well as those taking certain antifungal or HIV drugs. Avoid driving or hazardous tasks until you know how RAPAFLO will affect you, as a sudden drop in blood pressure may occur, rarely resulting in fainting. If considering cataract surgery, tell your eye surgeon you're currently taking RAPAFLO or have taken it in the past. Side effects include orgasm with reduced or no semen, dizziness, diarrhea, lightheadedness upon standing or sitting up abruptly, headache, swelling of the throat and nasal passages, and stuffy nose.